Market Overview:
The global epistaxis drugs market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of nosebleeds, rising awareness about available treatment options, and growing demand for minimally invasive procedures. The global epistaxis drugs market is segmented on the basis of type into vasoconstrictors, anesthetics, antibiotic ointments, cauterizing agents, and others. Vasoconstrictors are expected to account for the largest share of the global epistaxis drugs market in 2018 owing to their ability to reduce blood flow and control bleeding. Anesthetics are also expected to witness significant growth during the forecast period due to their ability to provide relief from pain and discomfort associated with nosebleeds. On the basis of application, hospitals are expected to account for the largest share of the global epistaxis drugs market in 2018 followed by clinics and retail pharmacies. The large share of this segment can be attributedtothe increasing numberof hospital admissionsfor nosebleedsand growing demandfor minimally invasive procedures such as endoscopic sinus surgeryand balloon sinuplastyin developed countries such as USto treat chronic rhinosinusitis (CRS).
Product Definition:
Epistaxis is a condition in which there is bleeding from the nose. Epistaxis drugs are medications that are used to treat this condition. These drugs work by helping to stop the bleeding and by reducing inflammation.
Vasoconstrictors:
Epistaxis is the medical term used for abnormal blood flow in the nose or mouth. It can be due to a number of reasons such as injury, infection, nasal surgery and other factors. The normal functioning of the body's natural vasoconstrictors (miniature arteries) is impaired owing to loss of blood volume or hypertension which results in reduced ability to constrict vessels resulting in increased bleeding tendency.
Anesthetics:
Anesthetics is a class of drugs that reduces the sensation of pain. They are used in surgical and nonsurgical procedures for reducing pain. The most common anesthetics used today include propofol, etomidate, and thiopental; these three account for more than 90% of all anesthetic drug sales worldwide. Anesthesia is one of the most commonly performed surgical procedure around the world with over 65 million surgeries being performed annually in U.
Application Insights:
Based on the application, the global market is segmented into hospitals, clinics, retail pharmacies and others. Hospitals held the largest share of over 70% in 2017. Epistaxis occurs frequently in hospital settings which requires treatment within a few minutes to hours of occurrence for avoiding complications such as loss of vision or life-threatening hemorrhage. Thus, hospitals are expected to be one of the major revenue generating centers owing to rising incidence rate and increasing awareness about timely treatment at right time for preventing any further complications or losses.
The clinics segment is anticipated to grow at a lucrative CAGR during forecast period due to rising number of cosmetic surgeries being performed worldwide coupled with growing disposable income levels among consumers especially in emerging regions such as Asia Pacific and Middle East & Africa countries that have higher incidences rate compared to North America and Europe regions respectively.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to rising incidence of epistaxis and growing awareness about its treatment options. In addition, presence of key players in this region is also expected to contribute toward the growth during the forecast period. Asia Pacific is expected to witness lucrative growth over the coming years owing to increasing geriatric population, which increases susceptibility towards various disorders including osteoporosis and hypertension, thereby leading to an increase in hospital admissions for epistaxis as well as other associated conditions such as sinusitis and otitis media.
Key players operating in this industry include B Braun AG; Cipla Inc.; Dr Reddy's Laboratories Ltd.
Growth Factors:
- Increasing incidence of nasal allergies and sinusitis
- Growing awareness about the benefits of Epistaxis Drugs over conventional treatments
- Rising demand for minimally invasive procedures for Epistaxis Drugs treatment
- Technological advancements in the field of Epistaxis Drugs therapy
- increasing prevalence of lifestyle diseases
Scope Of The Report
Report Attributes
Report Details
Report Title
Epistaxis Drugs Market Research Report
By Type
Vasoconstrictors, Anesthetics, Antibiotic Ointments, Cauterizing Agents, Others
By Application
Hospitals, Clinics, Retail Pharmacies, Others
By Companies
Pfizer, GlaxoSmithKline, Smith & Nephew, Bristol-Myers Squibb, Medline Industries, Ciron Drugs & Pharmaceuticals
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
204
Number of Tables & Figures
143
Customization Available
Yes, the report can be customized as per your need.
Global Epistaxis Drugs Market Report Segments:
The global Epistaxis Drugs market is segmented on the basis of:
Types
Vasoconstrictors, Anesthetics, Antibiotic Ointments, Cauterizing Agents, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Retail Pharmacies, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Pfizer
- GlaxoSmithKline
- Smith & Nephew
- Bristol-Myers Squibb
- Medline Industries
- Ciron Drugs & Pharmaceuticals
Highlights of The Epistaxis Drugs Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Vasoconstrictors
- Anesthetics
- Antibiotic Ointments
- Cauterizing Agents
- Others
- By Application:
- Hospitals
- Clinics
- Retail Pharmacies
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Epistaxis Drugs Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Epistaxis drugs are medications used to treat the symptoms of epistaxis, or nosebleeds. These drugs can include aspirin, ibuprofen, and other NSAIDs (nonsteroidal anti-inflammatory drugs).
Some of the major companies in the epistaxis drugs market are Pfizer, GlaxoSmithKline, Smith & Nephew, Bristol-Myers Squibb, Medline Industries, Ciron Drugs & Pharmaceuticals.
The epistaxis drugs market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Epistaxis Drugs Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Epistaxis Drugs Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Epistaxis Drugs Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Epistaxis Drugs Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Epistaxis Drugs Market Size & Forecast, 2020-2028
4.5.1 Epistaxis Drugs Market Size and Y-o-Y Growth
4.5.2 Epistaxis Drugs Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Vasoconstrictors
5.2.2 Anesthetics
5.2.3 Antibiotic Ointments
5.2.4 Cauterizing Agents
5.2.5 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Retail Pharmacies
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Epistaxis Drugs Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Epistaxis Drugs Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Vasoconstrictors
9.6.2 Anesthetics
9.6.3 Antibiotic Ointments
9.6.4 Cauterizing Agents
9.6.5 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Retail Pharmacies
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Vasoconstrictors
10.6.2 Anesthetics
10.6.3 Antibiotic Ointments
10.6.4 Cauterizing Agents
10.6.5 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Retail Pharmacies
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Vasoconstrictors
11.6.2 Anesthetics
11.6.3 Antibiotic Ointments
11.6.4 Cauterizing Agents
11.6.5 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Retail Pharmacies
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Vasoconstrictors
12.6.2 Anesthetics
12.6.3 Antibiotic Ointments
12.6.4 Cauterizing Agents
12.6.5 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Retail Pharmacies
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Vasoconstrictors
13.6.2 Anesthetics
13.6.3 Antibiotic Ointments
13.6.4 Cauterizing Agents
13.6.5 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Retail Pharmacies
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Epistaxis Drugs Market: Competitive Dashboard
14.2 Global Epistaxis Drugs Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Pfizer
14.3.2 GlaxoSmithKline
14.3.3 Smith & Nephew
14.3.4 Bristol-Myers Squibb
14.3.5 Medline Industries
14.3.6 Ciron Drugs & Pharmaceuticals
